GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (BSP:S1TE34) » Definitions » Short Interest

Steris (BSP:S1TE34) Short Interest


View and export this data going back to 2020. Start your Free Trial

What is Steris Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Steris's Short Interest

For the Medical Devices subindustry, Steris's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steris's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Short Interest distribution charts can be found below:

* The bar in red indicates where Steris's Short Interest falls into.


Steris (BSP:S1TE34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (BSP:S1TE34) » Definitions » Short Interest
Comparable Companies
ZBH ALGN PODD SWAV BRKR GMED BIO PEN MASI GKOS ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA XSWX:SOON
Traded in Other Exchanges
STE:USA
Address
5960 Heisley Road, Mentor, OH, USA, 44060
Website
https://www.steris-ir.com
Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

Steris (BSP:S1TE34) Headlines

No Headlines